XX9-10390-72365
2 vaccinations
7 coded responses
12 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 334 / FL
- Registered
- 2021-04-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-11
Dose 1 — Moderna
-
2021-04-08
Dose 2 — Moderna
-
2021-04-11
Registered in v-safe
-
2021-04-11
Survey response — days 1–6 daily, dose 2MedDRA: Dysgeusia, Pain in jaw, Toothache — Feeling: Poor · Site: Pain, Redness · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-04-13
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea, Hyperhidrosis — Feeling: Fair · Site: Redness · Headache, Joint pains, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-04-14
Survey response — days 1–6 daily, dose 2MedDRA: Rash, Rash macular — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-04-15
Survey response — 7 day, dose 2MedDRA: Rash — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-04-22
- 2021-04-29
-
2021-05-06
Survey response — 28 day, dose 2MedDRA: Rash, Rash macular — Feeling: GoodMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-05-15
- 2021-05-20
- 2021-07-10
-
2021-10-07
Survey response — 6 month, dose 2MedDRA: Hypoaesthesia, Paraesthesia — Feeling: GoodMedDRA releases: 2024-11 · check-in answers available
-
2022-04-08
Survey response — 12 month, dose 2MedDRA: Cardiac ablation, Supraventricular tachycardia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationMedDRA releases: 2024-11 · check-in answers available
-
2022-04-08
Report sent to call center — 12 month, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-04-14
-
2022-04-22
Callback requested for04:30PM ET
-
2022-04-22
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-11 | Moderna | |
| 2 | 2021-04-08 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-08 | Successful 2022-04-22 |
Participant prefers to complete VAERS report online |
Free text
Release 7
Systemic reaction (other): Jaw, teeth hurt amd metal taste in mouth
Systemic reaction (other): Sweating and shortness of breath but not severe and better than was
Systemic reaction (other): Rash is red blotches
Systemic reaction (other): Rash is dissepating.
Release 8
Symptoms: Had rash and now have little bumps not sure if related or not but did not have before and skin still blotchy. Not itchy though.
Release 10
Symptoms: Since my vaccine I have experienced tingling and numbness in my arm. May be related or may not.
Release 11
Symptoms: SVTs 286 heart rate. Cardiac oblation performed
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cardiac ablation | · | · | ✓ |
| SD | Hypoaesthesia | · | · | ✓ |
| SD | Paraesthesia | · | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Rash macular | ✓ | ✓ | ✓ |
| SD | Supraventricular tachycardia | · | · | ✓ |
| SRO | Dysgeusia | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
| SRO | Pain in jaw | ✓ | ✓ | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
| SRO | Rash macular | ✓ | ✓ | ✓ |
| SRO | Toothache | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release